Collaborative working is generally between one or more pharmaceutical companies, which either enhances patient care or is for the benefit of patients, or alternatively benefits the NHS. In accordance with clause 20 of the ABPI Code of Practice, the Mitsubishi Tanabe Pharma Group will publish an executive summary of any collaborative working (including joint working) agreements below before arrangements are implemented.

 

We have no Collaborative Working projects to announce at this time.